Franklin Andrew, Steele Edward J
Novartis Pharma AG, Novartis Campus, 4056, Basel, Switzerland.
Melville Analytics Pty Ltd, Melbourne, VIC 3000, Australia.
Trends Genet. 2022 May;38(5):426-436. doi: 10.1016/j.tig.2021.10.005. Epub 2021 Nov 2.
Somatic hypermutation at antibody loci affects both deoxyadenosine-deoxythymidine (A/T) and deoxycytidine-deoxyguanosine (C/G) pairs. Deamination of C to deoxyuridine (U) by activation-induced deaminase (AID) explains how mutation at C/G pairs is potentiated. Mutation at A/T pairs is triggered during the initial stages of repair of AID-generated U lesions and occurs through an as yet unknown mechanism in which polymerase η has a major role. Recent evidence confirms that human polymerase η can act as a reverse transcriptase. Here, we compare the popular suggestion of mutation at A/T pairs through nucleotide mispairing (owing to polymerase error) during short-patch repair synthesis with the alternative proposal of mutation at A/T pairs through RNA editing and RNA-directed DNA repair.
抗体基因座的体细胞超突变会影响脱氧腺苷-脱氧胸苷(A/T)和脱氧胞苷-脱氧鸟苷(C/G)碱基对。激活诱导的脱氨酶(AID)将C脱氨基为脱氧尿苷(U),这解释了C/G碱基对处的突变是如何被增强的。A/T碱基对处的突变在AID产生的U损伤修复的初始阶段被触发,并且通过一种尚未明确的机制发生,其中聚合酶η起主要作用。最近的证据证实,人类聚合酶η可以作为逆转录酶。在这里,我们将关于A/T碱基对处通过短片段修复合成过程中的核苷酸错配(由于聚合酶错误)导致突变的普遍观点,与关于A/T碱基对处通过RNA编辑和RNA指导的DNA修复导致突变的另一种观点进行比较。